Related Experiment Video

Updated: Jul 26, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K

Comparing the technical reliability and insulin dosing of a "do-it-yourself artificial pancreas" with a commercial

Juri Künzler1, Thomas Züger2, Christoph Stettler1

  • 1Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism UDEM, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Diabetes, Obesity & Metabolism
|June 13, 2023
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CSIIinsulin pump therapysubcutaneous injectiontype 1 diabetes

More Related Videos

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate05:58

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

Published on: June 25, 2019

7.5K
Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol08:04

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol

Published on: November 3, 2023

2.0K

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
215